As HMGB1 expression is now considered as anovel and independent predictor of decreased disease-free survival of patients with prostate cancer, it may also be reckoned as a new and independent predictor of prognosis for HCC patients. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.